In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

Startup inspiration can strike anywhere. But for Atlas.co*, a freemium browser-based, real-time mapping tool that's being ...

Offering new tools like Magnetic Mask and the highly anticipated... at 18:02 PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy PTC Therapeutics, Inc. announced today the U.S.

As we delve into this collection of notable alcohol logos, we will uncover the strategic thinking and design principles behind them. Learn more here! A logo is the face of a brand, encapsulating its ...